Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation
โ Scribed by Martin Neumann; Igor W. Blau; Thomas Burmeister; Carola Tietze-Buerger; Olga Blau; Armin Gerbitz; Lutz Uharek; Eckhard Thiel
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 216 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We report on three patients who developed overt thyrotoxicosis after volunteer unrelated donor bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia shortly after the onset of chronic graft versus host disease. In all three cases, the etiology of hyperthyroidism i
## Abstract Allogeneic hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with myelodysplastic syndrome (MDS). Relapses after transplantation however, are not uncommon and are usually due to reโemergence of a recipient derived, neoplastic, stem cell clone
## Abstract Donorโderived cytotoxic T lymphocytes (CTL) that respond to tumor antigens emerge after hematopoietic stem cell transplantation (HSCT), particularly in association with the status of immune recovery. To analyze the frequency of CTL against PR1, PRAME and WT1 after HSCT, a tetramerโbased
## Abstract Early reconstitution of lymphoid populations was monitored by immunophenotyping in 57 allogeneic peripheral blood stem cell (alloโPBSC) transplant patients either with or without cytomegalovirus (CMV) viremia or disease. Cell counts for total lymphocytes and CD4^+^ T cells above the per